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This isolated and severe yM deficiency can be classified as a dysgammaglobulinaemia. It is distinct from the GiedionScheidegger variety (type 1), where yA is also very low and where there is a continual history of all kinds of bacterial infections from birth. Case 4 initially showed a low yA and yM, but this may have been due to delay in immunological maturation, for both are now developing normally. Cases I and 2 are also distinct from the Wiskott-Aldrich syndrome (type VA), a sex-linked recessive condition usually fatal to affected males before 10 years of age, where though -yM deficiency appears it is usually associated with a marked increase of yA. Clinically there is a long history of eczema, thrombocytopenia, and recurrent infections from soon after birth. Cases 1 and 2 have therefore been classified as type VB by Hobbs et al. (1967a) . Furthermore, it is realized that isolated deficiency of yM can be found in apparently healthy subjects (type VO) and can be associated with defects of other classes of immunoglobulins in both sexes of given families (Burtin et al., 1964) . Thus the finding of yA deficiency in four other relatives of Cases 1 and 2 adds support to a genetic basis for their fatal abnormality.
Summary
Serum immunoglobulin levels and meningococcal antibodies were measured in nine patients suffering from meningococcal infection. The bactericidal activity of normal serum to meningococci could be attributed largely to yM globulin. Severe yM deficiency, probably inherited, was found in two boys dying from fulminating meningococcal septicaemia. Other evidence supported the view that yM antibodies are an important humoral defence mechanism and that the normal presence of these antibodies in the blood stream restrains systemic meningococcal infection to the C.S.F. (Quinton et al., 1960 (Quinton et al., , 1962 Hegstrom, 1961) . In spite of its considerable success this technique is far from perfect, and problems of infections and clotting remain as a major cause of trouble in the management of these patients. The average survival rate for external shunts varies considerably from one centre to another. In a series published from the Swedish Hospital in Seattle the mean shunt life for both arteries and veins varied from 11 days to 11.4 months (Murray et al., 1964) . In a more' recent review from the same centre (Pendras and Smith, 1966) an average cannula survival of 12 to 14 months was reported. This they attributed to the prevention of infection in the patient before and shortly after operation, and also by avoiding cannulation in the severely uraemic state.
We have been unable to achieve a similar standard of shunt survival since we began regular dialysis therapy in November 1964. Our survival rates in arteries and veins were 3.8 and 3.6 months respectively, the majority of the failures occurring 
Choice of Vessels and Site of Fistula Formation
In the early stages of this project we received patients who had had repeated shunt insertion. Frequently only ulnar arteries remained patent, the radial arteries having been cannulated. This does not make fistula formation impossible. Neither does it appear to impair seriously the blood supply to the hand if the sole remaining main vessel is used for fistula formation. In Tables I and 1I are given particulars of a series of 14 patients on regular dialysis treatment in whom an arteriovenous fistula was created surgically. (Fig. 2) . The lumen of both vessels is washed out with heparinized saline and a side-to-side anastomosis made in continuous fashion with 00000 polyethylene (Fig. 3) infiltrated subcutaneously with 0.5%' lignocaine without adrenaline. Initially the obtaining of a suitable puncture needle was a major problem. We tried a variety of needles, but were continuously faced with the problem of clotting of the needles in the lumen despite increasing the standard dose of heparin by 10,000 units. However, we realized that the quality of our needles was at fault, the surface of the inside of the lumen being rough. We now satisfactorily use a 1-in. (3.8-cm.) 14 gauge thin-walled smooth-bore needle (Bardic). The needles are attached to Tomac extension tubes (Fig. 4) . Firstly, the return-flow needle is inserted cephalically below the antecubital fossa and advanced maximally. The tourniquet is released and the standard dose of heparin is infused through this needle. Adequate time for heparinization is allowed. The tourniquet is now reapplied below the proximal needle and the outlet venepuncture is performed. If the needle is inserted proximal to the fistula it should be directed towards the hand, while if inserted distally it should point cephalically. The predialysis blood samples are taken from this latter tube. A light venous tourniquet is occasionally necessary between the needle insertions to ensure adequacy of flow. This is particularly so in the first few weeks after fistula formation, but later is unnecessary as the veins become distended and arterialized. Blood flow rates of 300 ml. per minute are easily obtainable by means of a roller type blood pump. Each dialysis lasts nine hours, and there is no falling off in the blood flow rates. At the completion of dialysis, protamine sulphate is infused. Each needle is removed at intervals of 10 minutes and digital pressure is applied by the patient along the line of venepuncture until haemostasis is obtained. This requires three to five minutes on an average. A light dressing is applied to the puncture sites, and the patient discards it after a few hours.
Comment
On our dialysis programme we use Kolff twin-coil machines, similar to those used by Brescia et al. (1966) 
Summary
An arteriovenous fistula was created surgically in 14 patients on regular dialysis treatment in order to provide repeated access to the circulation. In 11 patients the initial arteriovenous fistula functioned satisfactorily and without complications. In two patients in whom the initial fistula failed to function, success was achieved in the opposite forearm. In one patient in whom the procedure failed initially a second attempt to create a fistula has been postponed owing to the poor calibre of her veins and the urgency of maintaining adequate haemodialysis.
ADDENDUM.-Since this communication was submitted for publication two further patients have had successful arteriovenous fistulas established. In addition one patient (Case 9) in whom arteriovenous fistula formation on 31 January 1967 was unsuccessful and in whom a Quinton shunt was replaced has recently had a functioning fistula established by use of her remaining ulnar artery. In September 1967 the total number of patients with successful fistulas was therefore 16.
